Query 043233
Match_columns 125
No_of_seqs 59 out of 61
Neff 2.8
Searched_HMMs 46136
Date Fri Mar 29 02:47:33 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/043233.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/043233hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 cd01327 KAZAL_PSTI Kazal-type 99.0 2.8E-10 6E-15 71.0 3.0 38 49-89 3-45 (45)
2 PF00050 Kazal_1: Kazal-type s 98.9 9.9E-10 2.1E-14 68.8 2.8 34 51-89 8-48 (48)
3 smart00280 KAZAL Kazal type se 98.9 1.3E-09 2.9E-14 66.5 2.7 32 58-89 10-46 (46)
4 cd00104 KAZAL_FS Kazal type se 98.7 1.6E-08 3.4E-13 59.9 2.3 31 58-89 5-41 (41)
5 PF07648 Kazal_2: Kazal-type s 98.6 2.1E-08 4.5E-13 58.7 2.4 31 58-89 5-42 (42)
6 cd01328 FSL_SPARC Follistatin- 97.9 8.3E-06 1.8E-10 58.0 2.9 42 50-91 28-85 (86)
7 cd01330 KAZAL_SLC21 The kazal- 97.6 4.4E-05 9.6E-10 50.0 2.2 31 50-81 8-38 (54)
8 KOG4578 Uncharacterized conser 96.8 0.0005 1.1E-08 60.5 1.5 40 51-90 34-78 (421)
9 TIGR00805 oat sodium-independe 96.6 0.0014 3E-08 57.8 2.5 28 51-79 453-480 (633)
10 KOG3626 Organic anion transpor 95.7 0.0075 1.6E-07 56.3 3.0 43 50-93 517-582 (735)
11 KOG3555 Ca2+-binding proteogly 88.7 0.21 4.5E-06 44.7 1.3 43 48-92 139-186 (434)
12 COG5058 LAG1 Protein transport 83.5 0.83 1.8E-05 40.6 2.3 16 101-116 344-359 (395)
13 smart00057 FIMAC factor I memb 54.4 9.7 0.00021 26.0 1.8 32 59-90 31-68 (69)
14 PF12178 INCENP_N: Chromosome 42.1 11 0.00024 23.8 0.5 8 107-114 24-31 (38)
15 COG3350 Uncharacterized conser 40.6 14 0.0003 24.8 0.9 7 58-64 4-10 (53)
16 PHA02325 hypothetical protein 29.4 27 0.00057 24.8 0.8 15 60-74 7-24 (72)
17 PRK14762 membrane protein; Pro 26.9 65 0.0014 19.1 2.0 14 112-125 10-23 (27)
18 KOG1607 Protein transporter of 25.9 55 0.0012 28.5 2.3 16 101-116 266-281 (318)
19 KOG4004 Matricellular protein 20.6 38 0.00083 28.8 0.4 44 50-93 80-134 (259)
20 KOG4075 Cytochrome c oxidase, 20.4 66 0.0014 25.9 1.6 39 81-125 78-119 (167)
No 1
>cd01327 KAZAL_PSTI Kazal-type pancreatic secretory trypsin inhibitors (PSTI) and related proteins, including the second domain of the ovomucoid turkey inhibitor and the C-terminal domain of the esophagus cancer-related gene-2 protein (ECRG-2), are members of the superfamily of kazal-type proteinase inhibitors and follistatin-like proteins.
Probab=99.00 E-value=2.8e-10 Score=71.04 Aligned_cols=38 Identities=39% Similarity=0.816 Sum_probs=30.6
Q ss_pred ccCccCCcCCCceecCCCceecccch--hhhh---cCceeeeeecc
Q 043233 49 VSCPVKCFTTDPVCGMDGVTYWCGCD--EARC---AGATVAKKGFC 89 (125)
Q Consensus 49 ~~CPv~c~r~dpVCG~dGvTY~~gC~--~A~C---aGV~Vak~G~C 89 (125)
..||.. ++||||+||+||.|.|. .+.| ..+++.|+|.|
T Consensus 3 ~~Cp~~---~~PVCGsDg~TY~N~C~l~~~~c~~~~~i~~~~~G~C 45 (45)
T cd01327 3 FGCPKD---YDPVCGTDGVTYSNECLLCAENLKRQTNIRIKHDGEC 45 (45)
T ss_pred CCCCCC---CCceeCCCCCEeCCHhHHHHHHhccCCCeEEeecCCC
Confidence 467766 88999999999999996 2233 34899999988
No 2
>PF00050 Kazal_1: Kazal-type serine protease inhibitor domain; InterPro: IPR002350 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively. In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. This family of Kazal inhibitors, belongs to MEROPS inhibitor family I1, clan IA. They inhibit serine peptidases of the S1 family (IPR001254 from INTERPRO) []. The members are primarily metazoan, but includes exceptions in the alveolata (apicomplexa), stramenopiles, higher plants and bacteria. Kazal inhibitors, which inhibit a number of serine proteases (such as trypsin and elastase), belong to family of proteins that includes pancreatic secretory trypsin inhibitor; avian ovomucoid; acrosin inhibitor; and elastase inhibitor. These proteins contain between 1 and 7 Kazal-type inhibitor repeats [, ]. The structure of the Kazal repeat includes a large quantity of extended chain, 2 short alpha-helices and a 3-stranded anti-parallel beta sheet [].The inhibitor makes 11 contacts with its enzyme substrate: unusually, 8 of these important residues are hypervariable []. Altering the enzyme-contact residues, and especially that of the active site bond, affects the the strength of inhibition and specificity of the inhibitor for particular serine proteases [, ]. The presence of this Pfam domain is usually indicative of serine protease inhibitors, however, Kazal-like domains are also seen in the extracellular part of agrins which are not known to be proteinase inhibitors.; GO: 0005515 protein binding; PDB: 1HPT_A 1CGI_I 1CGJ_I 2P6A_D 3HH2_C 2B0U_D 2BUS_A 1BUS_A 1OVO_A 3OVO_A ....
Probab=98.90 E-value=9.9e-10 Score=68.81 Aligned_cols=34 Identities=50% Similarity=1.060 Sum_probs=26.6
Q ss_pred CccCCcCCCceecCCCceecccchhhhh-------cCceeeeeecc
Q 043233 51 CPVKCFTTDPVCGMDGVTYWCGCDEARC-------AGATVAKKGFC 89 (125)
Q Consensus 51 CPv~c~r~dpVCG~dGvTY~~gC~~A~C-------aGV~Vak~G~C 89 (125)
|| ..++||||+||+||.|.|.- | ..++++|+|.|
T Consensus 8 C~---~~~~PVCGsdg~TY~N~C~l--C~~~~~~~~~i~~~~~G~C 48 (48)
T PF00050_consen 8 CP---REYDPVCGSDGVTYSNECEL--CAANRRSGKNIRIAHDGPC 48 (48)
T ss_dssp EE---SSCS-EEETTSEEESSHHHH--HHHHHHTTTSS-EEEESS-
T ss_pred CC---CCCCceECCCCCCccccchh--hhhhcccCCCeEEeecCCC
Confidence 88 45899999999999999964 5 34999999998
No 3
>smart00280 KAZAL Kazal type serine protease inhibitors. Kazal type serine protease inhibitors and follistatin-like domains.
Probab=98.88 E-value=1.3e-09 Score=66.51 Aligned_cols=32 Identities=50% Similarity=0.973 Sum_probs=27.5
Q ss_pred CCceecCCCceecccch--hhhh---cCceeeeeecc
Q 043233 58 TDPVCGMDGVTYWCGCD--EARC---AGATVAKKGFC 89 (125)
Q Consensus 58 ~dpVCG~dGvTY~~gC~--~A~C---aGV~Vak~G~C 89 (125)
++||||+||+||.|.|. .++| ..+++.|+|.|
T Consensus 10 ~~pVCgsdg~TY~N~C~l~~~~c~~~~~i~~~~~G~C 46 (46)
T smart00280 10 YDPVCGSDGVTYSNECHLCKAACESGKSIEVKHDGPC 46 (46)
T ss_pred CCccCCCCCCEeCCHhHHHHHHhcCCCCeEEeecCCC
Confidence 78999999999999997 4555 34899999988
No 4
>cd00104 KAZAL_FS Kazal type serine protease inhibitors and follistatin-like domains. Kazal inhibitors inhibit serine proteases, such as, trypsin, chyomotrypsin, avian ovomucoids, and elastases. The inhibitory domain has one reactive site peptide bond, which serves the cognate enzyme as substrate. The reactive site peptide bond is a combining loop which has an identical conformation in all Kazal inhibitors and in all enzyme/inhibitor complexes. These Kazal domains (small hydrophobic core of alpha/beta structure with 3 to 4 disulfide bonds) often occur in tandem arrays. Similar domains are also present in follistatin (FS) and follistatin-like family members, which play an important role in tissue specific regulation. The FS domain consists of an N-terminal beta hairpin (FOLN/EGF-like domain) and a Kazal-like domain and has five disulfide bonds. Although the Kazal-like FS substructure is similar to Kazal proteinase inhibitors, no FS domain has yet been shown to be a proteinase inhibitor.
Probab=98.65 E-value=1.6e-08 Score=59.85 Aligned_cols=31 Identities=55% Similarity=0.985 Sum_probs=25.8
Q ss_pred CCceecCCCceecccchhhhhc------Cceeeeeecc
Q 043233 58 TDPVCGMDGVTYWCGCDEARCA------GATVAKKGFC 89 (125)
Q Consensus 58 ~dpVCG~dGvTY~~gC~~A~Ca------GV~Vak~G~C 89 (125)
+.||||+||+||.|.|. +.|+ ++.+.++|.|
T Consensus 5 ~~pVCgsdg~tY~n~C~-~~~~~c~~~~~~~~~~~g~C 41 (41)
T cd00104 5 YDPVCGSDGKTYSNECH-LGCAACRSGRSITVAHNGPC 41 (41)
T ss_pred CCccCCCCCCEECCHhh-hhHHhhcCCCCeEEEeccCC
Confidence 58999999999999995 5553 4888888887
No 5
>PF07648 Kazal_2: Kazal-type serine protease inhibitor domain; InterPro: IPR011497 This domain is usually indicative of serine protease inhibitors that belong to Merops inhibitor families: I1, I2, I17 and I31. However, kazal-like domains are also seen in the extracellular part of agrins, which are not known to be protease inhibitors. Kazal domains often occur in tandem arrays and have a central alpha-helix, a short two-stranded antiparallel beta-sheet and several disulphide bonds [, , ]. The amino terminal segment of this domain binds to the active site of its target proteases, thus inhibiting their function.; PDB: 2KMP_A 1LDT_L 2KMR_A 2KMO_A 2KMQ_A 1AN1_I 4E0S_B 3T5O_A 4A5W_B 1LR7_A ....
Probab=98.63 E-value=2.1e-08 Score=58.74 Aligned_cols=31 Identities=42% Similarity=0.949 Sum_probs=26.0
Q ss_pred CC-ceecCCCceecccchhhhh------cCceeeeeecc
Q 043233 58 TD-PVCGMDGVTYWCGCDEARC------AGATVAKKGFC 89 (125)
Q Consensus 58 ~d-pVCG~dGvTY~~gC~~A~C------aGV~Vak~G~C 89 (125)
++ ||||+||+||.|.|. ..+ ..++++++|.|
T Consensus 5 ~~~PVCg~dg~ty~n~C~-l~~~~c~~~~~~~~~~~g~C 42 (42)
T PF07648_consen 5 YSSPVCGSDGKTYSNECE-LRCANCRTNSKIQIVHDGSC 42 (42)
T ss_dssp SSSTEEETTSEEESSHHH-HHHHHHHHTTTCEEEEESSS
T ss_pred CCCCEEcCCCCEEhhHHH-HHHHHHhcCCCeEEEeCCCC
Confidence 44 999999999999996 444 35999999988
No 6
>cd01328 FSL_SPARC Follistatin-like SPARC (secreted protein, acidic, and rich in cysteines) domain; SPARC/BM-40/osteonectin is a multifunctional glycoprotein which modulates cellular interaction with the extracellular matrix by its binding to structural matrix proteins such as collagen and vitronectin. The protein it composed of an N-terminal acidic region, a follistatin (FS) domain and an EF-hand calcium binding domain. The FS domain consists of an N-terminal beta hairpin (FOLN/EGF-like domain) and a small hydrophobic core of alpha/beta structure (Kazal domain) and has five disulfide bonds and a conserved N-glycosylation site. The FSL_SPARC domain is a member of the superfamily of kazal-like proteinase inhibitors and follistatin-like proteins.
Probab=97.92 E-value=8.3e-06 Score=57.95 Aligned_cols=42 Identities=26% Similarity=0.548 Sum_probs=32.0
Q ss_pred cCccCCcCCCceecCCCceecccch--hhhhc--------------CceeeeeeccCC
Q 043233 50 SCPVKCFTTDPVCGMDGVTYWCGCD--EARCA--------------GATVAKKGFCQV 91 (125)
Q Consensus 50 ~CPv~c~r~dpVCG~dGvTY~~gC~--~A~Ca--------------GV~Vak~G~Cev 91 (125)
.||-.-....+|||+||+||.|.|. +++|. -++|.+.|.|..
T Consensus 28 ~Cp~~~~~~~~VCGsDg~TY~s~C~L~r~~C~~~~~~~~~~~~~~~~l~i~Y~G~Ck~ 85 (86)
T cd01328 28 PCPEEVDDRRKVCTNDNETFDSDCELYRTRCLCKGGKKGCRGPKYQHLHLDYYGECKE 85 (86)
T ss_pred cCCCCCCCCCceeCCCCCCcccHhHHhhhHhccCCCCcCCCCCccCeEEEEeeccccC
Confidence 3664422236799999999999998 67774 588999999963
No 7
>cd01330 KAZAL_SLC21 The kazal-type serine protease inhibitor domain has been detected in an extracellular loop region of solute carrier 21 (SLC21) family members (organic anion transporters) , which may regulate the specificity of anion uptake. The KAZAL_SLC21 domain is a member of the superfamily of kazal-like proteinase inhibitors and follistatin-like proteins.
Probab=97.58 E-value=4.4e-05 Score=49.97 Aligned_cols=31 Identities=35% Similarity=0.909 Sum_probs=25.4
Q ss_pred cCccCCcCCCceecCCCceecccchhhhhcCc
Q 043233 50 SCPVKCFTTDPVCGMDGVTYWCGCDEARCAGA 81 (125)
Q Consensus 50 ~CPv~c~r~dpVCG~dGvTY~~gC~~A~CaGV 81 (125)
.|.+.-..++||||+||+||.+.| .|.|...
T Consensus 8 ~C~C~~~~~~PVCg~~g~tY~SpC-~AGC~~~ 38 (54)
T cd01330 8 NCSCSESAYSPVCGENGITYFSPC-HAGCTNS 38 (54)
T ss_pred CCCCCCCCcCCccCCCCCEEcCHh-HcCCccc
Confidence 455555568899999999999999 6999764
No 8
>KOG4578 consensus Uncharacterized conserved protein, contains KAZAL and TY domains [General function prediction only]
Probab=96.82 E-value=0.0005 Score=60.55 Aligned_cols=40 Identities=35% Similarity=0.899 Sum_probs=33.6
Q ss_pred CccCCcC-CCceecCCCceecccch--hhhhcC--ceeeeeeccC
Q 043233 51 CPVKCFT-TDPVCGMDGVTYWCGCD--EARCAG--ATVAKKGFCQ 90 (125)
Q Consensus 51 CPv~c~r-~dpVCG~dGvTY~~gC~--~A~CaG--V~Vak~G~Ce 90 (125)
|-..|.+ .+||||+||.||..+|. +|+|.+ +.++++|.|+
T Consensus 34 c~l~C~~~~kPvCasDGrty~srCe~qRAkC~dpql~~~yrG~Ck 78 (421)
T KOG4578|consen 34 CQLECDDNEKPVCASDGRTYPSRCELQRAKCGDPQLSLKYRGSCK 78 (421)
T ss_pred hccccCCCCCCccccCCccchhHHHHHHhhcCCCceeEEecCcHH
Confidence 4444544 47999999999999998 899988 7889999997
No 9
>TIGR00805 oat sodium-independent organic anion transporter. Proteins of the OAT family catalyze the Na+-independent facilitated transport of organic anions such as bromosulfobromophthalein and prostaglandins as well as conjugated and unconjugated bile acids (taurocholate and cholate, respectively). These transporters have been characterized in mammals, but homologues are present in C. elegans and A. thaliana. Some of the mammalian proteins exhibit a high degree of tissue specificity. For example, the rat OAT is found at high levels in liver and kidney and at lower levels in other tissues. These proteins possess 10-12 putative a-helical transmembrane spanners. They may catalyze electrogenic anion uniport or anion exchange.
Probab=96.57 E-value=0.0014 Score=57.79 Aligned_cols=28 Identities=39% Similarity=0.937 Sum_probs=23.1
Q ss_pred CccCCcCCCceecCCCceecccchhhhhc
Q 043233 51 CPVKCFTTDPVCGMDGVTYWCGCDEARCA 79 (125)
Q Consensus 51 CPv~c~r~dpVCG~dGvTY~~gC~~A~Ca 79 (125)
|-|.-..++||||.||+||-..| -|.|.
T Consensus 453 C~C~~~~~~PVCg~~~~tY~SpC-~AGC~ 480 (633)
T TIGR00805 453 CSCDSSFFDPVCGDNGLAYLSPC-HAGCS 480 (633)
T ss_pred CCCCCCCcccccCCCCCEEECcc-ccCCC
Confidence 55655679999999999999888 58875
No 10
>KOG3626 consensus Organic anion transporter [Secondary metabolites biosynthesis, transport and catabolism]
Probab=95.75 E-value=0.0075 Score=56.31 Aligned_cols=43 Identities=40% Similarity=0.909 Sum_probs=33.1
Q ss_pred cCccCCcCCCceecCCCceecccchhhhh------------------c-----CceeeeeeccCCCC
Q 043233 50 SCPVKCFTTDPVCGMDGVTYWCGCDEARC------------------A-----GATVAKKGFCQVGD 93 (125)
Q Consensus 50 ~CPv~c~r~dpVCG~dGvTY~~gC~~A~C------------------a-----GV~Vak~G~Cevg~ 93 (125)
.|-|+-.++.||||.||.||-..|- |.| . +..++++|+|+...
T Consensus 517 ~C~C~~~~~~PVCg~~G~tY~SpCh-AGC~~~~~~~~~~~~ytnCsCv~~~~~~~~~a~~G~C~~~c 582 (735)
T KOG3626|consen 517 DCSCDTSEYEPVCGENGITYFSPCH-AGCTESSGTSDGNTIYTNCSCVPTNKNGNGSAKKGYCPNDC 582 (735)
T ss_pred CCCCCCcCcCcccCCCCCEEeChhh-hCCcccccCCCCceeeccccccccccCCCceeecCCCCCCc
Confidence 4667767899999999999976662 333 2 46788999999875
No 11
>KOG3555 consensus Ca2+-binding proteoglycan Testican [General function prediction only]
Probab=88.74 E-value=0.21 Score=44.66 Aligned_cols=43 Identities=35% Similarity=0.635 Sum_probs=32.2
Q ss_pred CccCccCCcCCCceecCCCceecccch--hhhh---cCceeeeeeccCCC
Q 043233 48 PVSCPVKCFTTDPVCGMDGVTYWCGCD--EARC---AGATVAKKGFCQVG 92 (125)
Q Consensus 48 a~~CPv~c~r~dpVCG~dGvTY~~gC~--~A~C---aGV~Vak~G~Cevg 92 (125)
...|||- ...+|||+||-||+..|. .-+| .-++|.-+|+|.--
T Consensus 139 CKpCpva--q~a~vCGsDghtYss~ckLe~~aC~~sksiav~c~g~cpcp 186 (434)
T KOG3555|consen 139 CKPCPVA--QPAFVCGSDGHTYSSRCKLEYHACHVSKSIAVICEGPCPCP 186 (434)
T ss_pred CccCCcc--cccceecCCCCeehhhhhHHHHhhhhhhhhhhhhCCCCCCC
Confidence 3468875 356999999999999997 3455 23677888998764
No 12
>COG5058 LAG1 Protein transporter of the TRAM (translocating chain-associating membrane) superfamily, longevity assurance factor [Intracellular trafficking and secretion]
Probab=83.51 E-value=0.83 Score=40.58 Aligned_cols=16 Identities=56% Similarity=0.868 Sum_probs=13.6
Q ss_pred hhHHHHHHHHHHHHHH
Q 043233 101 SAQALLLVHIVWLIII 116 (125)
Q Consensus 101 ~~qalllvhivwl~vl 116 (125)
--||||||||+|++++
T Consensus 344 Ll~aLQlvniyWl~lI 359 (395)
T COG5058 344 LLQALQLVNIYWLFLI 359 (395)
T ss_pred HHHHHHHHHHHHHHHH
Confidence 3589999999999864
No 13
>smart00057 FIMAC factor I membrane attack complex.
Probab=54.40 E-value=9.7 Score=25.97 Aligned_cols=32 Identities=25% Similarity=0.465 Sum_probs=25.0
Q ss_pred CceecCCCcee--cccch--hhhhcC--ceeeeeeccC
Q 043233 59 DPVCGMDGVTY--WCGCD--EARCAG--ATVAKKGFCQ 90 (125)
Q Consensus 59 dpVCG~dGvTY--~~gC~--~A~CaG--V~Vak~G~Ce 90 (125)
..||..|+.+| -+.|. .-+|.| ..+.+.|.|+
T Consensus 31 ~~vCv~~~~~~~t~S~C~~~a~~C~g~~~~~~~~g~C~ 68 (69)
T smart00057 31 TDVCVEDGRSEKTLTYCKQKSLECLNPKYKFLHIGSCT 68 (69)
T ss_pred CCeeEecCceeeeecHHHHHHHHhcCCCcEEeccCCCC
Confidence 48999988888 56665 456777 7889999996
No 14
>PF12178 INCENP_N: Chromosome passenger complex (CPC) protein INCENP N terminal; InterPro: IPR022006 This domain family is found in eukaryotes, and is approximately 40 amino acids in length. INCENP is a regulatory protein in the chromosome passenger complex. It is involved in regulation of the catalytic protein Aurora B. It performs this function in association with two other proteins - Survivin and Borealin. These proteins form a tight three-helical bundle. The N-terminal domain is the domain involved in formation of this three helical bundle. ; PDB: 2QFA_C.
Probab=42.07 E-value=11 Score=23.77 Aligned_cols=8 Identities=38% Similarity=0.713 Sum_probs=6.3
Q ss_pred HHHHHHHH
Q 043233 107 LVHIVWLI 114 (125)
Q Consensus 107 lvhivwl~ 114 (125)
-+|+|||=
T Consensus 24 ~~d~vWLe 31 (38)
T PF12178_consen 24 NKDMVWLE 31 (38)
T ss_dssp HTHHHHHH
T ss_pred chhhHHHH
Confidence 47999983
No 15
>COG3350 Uncharacterized conserved protein [Function unknown]
Probab=40.61 E-value=14 Score=24.82 Aligned_cols=7 Identities=86% Similarity=1.782 Sum_probs=5.5
Q ss_pred CCceecC
Q 043233 58 TDPVCGM 64 (125)
Q Consensus 58 ~dpVCG~ 64 (125)
.|||||.
T Consensus 4 iDPVcgm 10 (53)
T COG3350 4 IDPVCGM 10 (53)
T ss_pred ccCCcCc
Confidence 5788886
No 16
>PHA02325 hypothetical protein
Probab=29.42 E-value=27 Score=24.82 Aligned_cols=15 Identities=53% Similarity=1.356 Sum_probs=12.5
Q ss_pred ceecC---CCceecccch
Q 043233 60 PVCGM---DGVTYWCGCD 74 (125)
Q Consensus 60 pVCG~---dGvTY~~gC~ 74 (125)
|+||+ ||--||+|=.
T Consensus 7 PkC~A~WldgqhYWsgTg 24 (72)
T PHA02325 7 PKCGARWLDGQHYWSGTG 24 (72)
T ss_pred CccCCEeEcceeeeccCC
Confidence 78898 9999999643
No 17
>PRK14762 membrane protein; Provisional
Probab=26.89 E-value=65 Score=19.13 Aligned_cols=14 Identities=36% Similarity=0.821 Sum_probs=10.4
Q ss_pred HHHHHHHHHHhhcC
Q 043233 112 WLIIIGISVLFGLF 125 (125)
Q Consensus 112 wl~vlg~~vl~g~f 125 (125)
-.++.|+.+++|.|
T Consensus 10 iifligllvvtgvf 23 (27)
T PRK14762 10 IIFLIGLLVVTGVF 23 (27)
T ss_pred HHHHHHHHHHHHHH
Confidence 34677888888865
No 18
>KOG1607 consensus Protein transporter of the TRAM (translocating chain-associating membrane) superfamily [Intracellular trafficking, secretion, and vesicular transport]
Probab=25.94 E-value=55 Score=28.48 Aligned_cols=16 Identities=44% Similarity=0.769 Sum_probs=12.8
Q ss_pred hhHHHHHHHHHHHHHH
Q 043233 101 SAQALLLVHIVWLIII 116 (125)
Q Consensus 101 ~~qalllvhivwl~vl 116 (125)
--++||++||.|...+
T Consensus 266 lL~~Lqll~i~W~~lI 281 (318)
T KOG1607|consen 266 LLLALQLLHIYWFYLI 281 (318)
T ss_pred HHHHHHHHHHHHHHHH
Confidence 3578999999998754
No 19
>KOG4004 consensus Matricellular protein Osteonectin/SPARC/BM-40 [Extracellular structures]
Probab=20.61 E-value=38 Score=28.81 Aligned_cols=44 Identities=23% Similarity=0.511 Sum_probs=29.6
Q ss_pred cCcc-CCcCCCceecCCCceecccch--hhhh--------cCceeeeeeccCCCC
Q 043233 50 SCPV-KCFTTDPVCGMDGVTYWCGCD--EARC--------AGATVAKKGFCQVGD 93 (125)
Q Consensus 50 ~CPv-~c~r~dpVCG~dGvTY~~gC~--~A~C--------aGV~Vak~G~Cevg~ 93 (125)
.||- .-...+-|||-|..||..-|. .-+| +.+..-+.|.|.--.
T Consensus 80 kCP~~~~~p~~KVC~nnNqTf~S~C~~~~~~C~~~~~~k~~k~hl~y~G~Ck~i~ 134 (259)
T KOG4004|consen 80 KCPRKQQRPVHKVCGNNNQTFNSWCEMHKHSCESRYFIKVHKLHLKYQGSCKYIP 134 (259)
T ss_pred CCCcccCCchhhhhcCCCcchhHHHHHHHhhhhhhcccccceeehhcccccccCC
Confidence 4776 333356899999999988776 2333 224557788888654
No 20
>KOG4075 consensus Cytochrome c oxidase, subunit IV/COX5b [Energy production and conversion]
Probab=20.37 E-value=66 Score=25.91 Aligned_cols=39 Identities=18% Similarity=0.204 Sum_probs=24.4
Q ss_pred ceeeeeeccCCCC---CCcccchhhHHHHHHHHHHHHHHHHHHHhhcC
Q 043233 81 ATVAKKGFCQVGD---NGGTASLSAQALLLVHIVWLIIIGISVLFGLF 125 (125)
Q Consensus 81 V~Vak~G~Cevg~---g~~~a~~~~qalllvhivwl~vlg~~vl~g~f 125 (125)
+...+.-+||.+. -++ .- =-.|-++|++++||.+.+++|
T Consensus 78 kalYrisF~et~ae~~~~~----~e--wKtv~g~~~~f~Gl~~~v~l~ 119 (167)
T KOG4075|consen 78 KALYRISFGETFAERNRGS----NE--WKTVFGVAGFFLGLTISVILF 119 (167)
T ss_pred HHHHHHHhccccccccCCC----Cc--ccchhhHHHHHHHHHHHHHHH
Confidence 5567777888432 110 00 113557899999999988765
Done!